Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Millar

Showing results (421-430 of 475) with videos related to

Pageof 48
Sort By:
Gene|January 1, 1985
Segments of chromosomal DNA from Rhynchosciara americana that undergo additional rounds of DNA replication in the salivary gland DNA puffs have only weak ARS activity in yeastS Millar, D C Hayward, C A Read, et al.
Journal of Lipid Research|February 1, 2017
Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transportTakashi Kuwano, Xin Bi, Eleonora Cipollari, et al.
Journal of Lipid Research|February 6, 2015
Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinAndrea J Luthi, Nicholas N Lyssenko, Duyen Quach, et al.
Journal of Lipid Research|February 6, 2009
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolismMargaret E Brousseau, John S Millar, Margaret R Diffenderfer, et al.
Thrombosis and Haemostasis|January 1, 1997
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisD A Lane, T Bayston, R J Olds, et al.
The New England Journal of Medicine|January 12, 2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemiaMarina Cuchel, LeAnne T Bloedon, Philippe O Szapary, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2021
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief ReportLaurens F Reeskamp, John S Millar, Liya Wu, et al.
Molecular and Cellular Endocrinology|October 28, 2008
Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African populationDavid S Millar, Mark D Lewis, Martin Horan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2008
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivoWilliam R Lagor, Robert J Brown, Sue-Anne Toh, et al.
Journal of Lipid Research|April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolismMargaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.
Pageof 48

Showing results (421-430 of 475) with videos related to

Sort By:
Pageof 48
Gene|January 1, 1985
Segments of chromosomal DNA from Rhynchosciara americana that undergo additional rounds of DNA replication in the salivary gland DNA puffs have only weak ARS activity in yeastS Millar, D C Hayward, C A Read, et al.
Journal of Lipid Research|February 1, 2017
Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transportTakashi Kuwano, Xin Bi, Eleonora Cipollari, et al.
Journal of Lipid Research|February 6, 2015
Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinAndrea J Luthi, Nicholas N Lyssenko, Duyen Quach, et al.
Journal of Lipid Research|February 6, 2009
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolismMargaret E Brousseau, John S Millar, Margaret R Diffenderfer, et al.
Thrombosis and Haemostasis|January 1, 1997
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisD A Lane, T Bayston, R J Olds, et al.
The New England Journal of Medicine|January 12, 2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemiaMarina Cuchel, LeAnne T Bloedon, Philippe O Szapary, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2021
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief ReportLaurens F Reeskamp, John S Millar, Liya Wu, et al.
Molecular and Cellular Endocrinology|October 28, 2008
Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African populationDavid S Millar, Mark D Lewis, Martin Horan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2008
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivoWilliam R Lagor, Robert J Brown, Sue-Anne Toh, et al.
Journal of Lipid Research|April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolismMargaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.
Pageof 48